Food, Drug, and Cosmetic Colors: Toxicological Considerations - ACS

Jul 23, 2009 - Department of Pharmacology and Toxicology, Medical College of ... These studies were supported by the Certified Colors Manufacturers As...
0 downloads 0 Views 1MB Size
20 Food, Drug, and Cosmetic Colors: Toxicological Considerations

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

JOSEPH F. BORZELLECA Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298 JOHN HALLAGAN and CAROLINE REESE The Offices of Daniel R. Thompson, 900 17th St. N.W., Washington, DC 20006

The Food, Drug and Cosmetic (FD&C) Colors have been studied extensively. The most recent have been chronic toxicity/oncogenicity studies in Charles River CD rats and Charles River CD-1 mice. The colors evaluated and the dietary levels employed were: Dietary Levels (%) Color Rat Mouse FD&C Blue 1 0.0, 0.1, 1.0, 2.0 0.0, 0.5, 1.5, 5.0 FD&C Green 3 0.0, 1.25, 2.5, 5.0 0.0, 0.5, 1.5, 5.0 FD&C Blue 2 0.0, 0.5, 1.0, 2.0 0.0, 0.5, 1.5, 5.0 FD&C Yellow 6 0.0, 0.75, 1.5, 3.0, 5.0 0.0, 0.5, 1.5, 5.0 FD&C Yellow 5 0.0, 0.1, 1.0, 2.0, 5.0 0.0, 0.5, 1.5, 5.0 FD&C Red 3 0.0, 0.1, 0.5, 1.0, 4.0 0.0, 0.3, 1.0, 3.0 Many parameters were measured during the course of these studies including reproductive performance (rats only), body weights, feed consumption, clinical chemistries (blood, urine), hematology, gross and histological examination of tissues. Data were subjected to extensive statistical analyses. There were no consistent statistically significant and biologically relevant compound related effects, including tumors. These studies were supported by the Certified Colors Manufacturers Association and were conducted by Bio-dynamics Laboratory and International Reseach and Development Corporation. C o l o r s have been an e s s e n t i a l p a r t o f o u r e x i s t e n c e . N a t u r e i s c o l o r f u l . C o l o r s have been used t h r o u g h o u t h i s t o r y b y man i n a t l e a s t t h r e e m a j o r a r e a s - f o o d , d r u g s and c o s m e t i c s . C o l o r e d c a n d y h a s been i d e n t i f i e d i n p a i n t i n g s i n E g y p t i a n tombs d a t i n g 0097-6156/83/0234-0311$06.50/0 © 1983 A m e r i c a n C h e m i c a l S o c i e t y

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

312

X E N O B I O T I C S IN F O O D S A N D

FEEDS

back t o a b o u t 1500 B.C. A r t i f i c i a l l y c o l o r e d w i n e s were r e p o r t e d b y P l i n y t h e E l d e r i n a b o u t 400 B.C. Ebers Papyrus, t h e o l d e s t r e c o r d o f d r u g s , i d e n t i f i e s c o l o r s t h a t were used i n drugs. A b o u t 5000 B.C., E g y p t i a n s were u s i n g g r e e n c o p p e r f o r eye shadow. A l s o u s e d were henna t o dye h a i r , c a r m i n e t o r e d d e n l i p s , k o h l (an a n t i m o n y compound) t o b l a c k e n e y e b r o w s , l i d s a n d l a s h e s . A r o u n d 500 B.C., s a f f r o n was u s e d t o make f a c e s y e l l o w and henna t o dye f e e t r e d i n I n d i a . C h i n e s e used v e g e t a b l e d y e s on f e e t , c h e e k s , and t i p s o f t h e i r t o n g u e s f o r v a r i o u s r e a s o n s . The Romans u s e d w h i t e l e a d and c h a l k o n t h e i r f a c e s and b l u e and g o l d dye o n t h e i r h a i r . The s o u r c e s o f d y e s u s e d b y man i n c l u d e a n i m a l , v e g e t a b l e , and m i n e r a l . S i r W i l l i a m H e n r y P e r k i n s , i n 1856, synthesized t h e f i r s t a n i l i n e dye. I n I 8 6 0 , a t r i p h e n y l m e t h a n e dye, f u c h s i n e , was u s e d b y t h e F r e n c h t o c o l o r w i n e . On A u g u s t 2, 1886, t h e U.S. C o n g r e s s a u t h o r i z e d t h e a d d i t i o n o f c o l o r t o b u t t e r . On J u n e 6, 1896, C o n g r e s s a p p r o v e d c o l o r a n t s i n c h e e s e , a n d b y 1900 c o l o r a n t s were added t o c a t s u p , j e l l i e s , c o r d i a l s , c a n d i e s , sausage and noodles. However, t h e r e were some c o n c e r n s b y t h e p u b l i c . F o r example, chrome y e l l o w , m a r t i u s y e l l o w a n d q u i c k s i l v e r v e r m i l l i o n were added t o f o o d s t o h i d e p o o r q u a l i t y o r t o i n c r e a s e w e i g h t . T h e r e was no c o n t r o l o v e r t h e p u r i t y o f c o l o r a n t s u s e d . F o r e x a m p l e , i t h a s been n o t e d t h a t r e j e c t e d t e x t i l e d y e s were sometimes added t o f o o d s . Use o f a r s e n i c a c i d and m e r c u r y i n t h e m a n u f a c t u r e o f c o l o r a n t s a l s o c r e a t e d some concerns. In 1899, t h e N a t i o n a l C o n f e c t i o n e r s A s s o c i a t i o n p u b l i s h e d a l i s t o f u n f i t c o l o r a n t s f o r f o o d s . T h i s was t h e f i r s t t i m e t h a t any g r o u p a d d r e s s e d t h e i s s u e o f s a f e t y o f c o l o r a n t s . Unfort u n a t e l y , t h i s was n o t v e r y e f f e c t i v e . I n A u g u s t , 1904, t h e U.S.D.A. i s s u e d a F o o d I n s p e c t i o n D e c i s i o n w h i c h s t a t e d , "Food i s a d u l t e r a t e d i f i t i s c o l o r e d , powdered o r p o l i s h e d w i t h attempt t o deceive." A n o t h e r F o o d I n s p e c t i o n D e c i s i o n was i s s u e d i n September 1905 i n w h i c h t h e U.S.D.A. r e q u i r e d t h a t c o l o r s must b e d e c l a r e d on l a b e l s . I n 1906 t h e U.S.D.A. d e c l a r e d m a r t i u s y e l l o w i n m a c a r o n i t o be an u n s a f e c o l o r ; a n d i n 1907 t h e F.D.A. p r o h i b i t e d t h e u s e o f d a n g e r o u s and impure c o l o r a n t s i n f o o d . T h e Food a n d Drug A c t was p a s s e d i n 1906. Dr. B e r n a r d C. H e s s e o f t h e U.S. D e p a r t m e n t o f A g r i c u l t u r e had e v a l u a t e d t h e c h e m i s t r y and p h y s i o l o g y o f a p p r o x i m a t e l y 700 c o a l t a r d y e s . O n l y c o l o r s o f known c o m p o s i t i o n were examined p h y s i o l o g i c a l l y . T h o s e s h o w i n g n o n - f a v o r a b l e r e s u l t s c o u l d be u s e d i n f o o d s . The U.S.D.A. began t o c e r t i f y s y n t h e t i c o r g a n i c f o o d c o l o r s i n A p r i l 1908. T h e c o s t o f t h e c e r t i f i c a t i o n was t o b e b o r n e b y i n d u s t r y (and s t i l l i s ) . T h e c o l o r s a p p r o v e d a t t h a t t i m e were amaranth (Red 2 ) , p o n c e a u 3R ( O r a n g e 1 ) , e r y t h r o s i n e (Red 3 ) , n a p h t h o l y e l l o w S ( Y e l l o w 7 ) , l i g h t g r e e n SF y e l l o w i s h , and i n d i g o d i s u l f o a c i d s o d i u m s a l t ( B l u e 2 ) . O t h e r c o l o r s were added: i n 1916, t a r t r a z i n e ( Y e l l o w 5 ) ; i n 1927, FCF g r e e n

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

20.

BORZELLECA ET AL.

Food,

Drug,

and Cosmetic

Colors

313

G r e e n 3 ) ; a n d 1 9 2 9 p o n c e a u SX ( R e d 4 ) , s u n s e t y e l l o w SCF Y e l l o w 6 ) , a n d b r i l l i a n t b l u e SCF ( B l u e 1 ) . I n 1938, t h e F e d e r a l F o o d , Drug and C o s m e t i c A c t was p a s s e d . I t s t a t e d t h a t u n c e r t i f i e d c o a l t a r c o l o r s i n food, drugs and cosmetics could n o t b e s h i p p e d i n i n t e r s t a t e commerce. U s e o f c o l o r s was l i m i t e d . A l l c o l o r s h a d t o be c e r t i f i e d a n d h a r m l e s s . T h r e e c a t e g o r i e s o f c o a l t a r c o l o r s were e s t a b l i s h e d : F o o d , Drug a n d C o s m e t i c c o l o r s , Drug and C o s m e t i c c o l o r s , a n d E x t e r n a l Drug and C o s m e t i c c o l o r s . T h e S e r v i c e and R e g u l a t o r y Announcement, FD and C No. 3, September 1940, l i s t e d c o l o r s t h a t were a p p r o v e d a t t h a t time and t h e s p e c i f i c a t i o n and r e g u l a t i o n s concerning manufacturing, c e r t i f i c a t i o n , sale, etc. T h e F o o d and Drug A d m i n i s t r a t i o n began t e s t i n g c o l o r s i n t h e e a r l y 1950s f o l l o w i n g an i n c i d e n t i n w h i c h c h i l d r e n became s i c k a f t e r e a t i n g c a n d y and colored popcorn. Unfavorable f i n d i n g s r e s u l t e d i n the banning o f FD a n d C Orange 1, FD and C Orange 2, and FD and C Red 3 2 . The FDA's p o s i t i o n was t h a t t h e t e r m h a r m l e s s n e s s a s d e f i n e d i n t h e 1938 A c t meant s a f e r e g a r d l e s s o f t h e amount u s e d . Later, t h e Supreme C o u r t r u l e d t h a t t h e F o o d a n d Drug A d m i n i s t r a t i o n could n o t e s t a b l i s h l i m i t s unless t h e c e r t i f i e d c o l o r i n any q u a n t i t y c a u s e d harm. T h e C o l o r A d d i t i v e s Amendment o f 1960 (PL-86-618) r e q u i r e d t h e f o l l o w i n g : e x i s t i n g c o l o r s c o u l d be u s e d p e n d i n g f u r t h e r t e s t i n g ; l i m i t s o f u s e were e s t a b l i s h e d ; a l l c o l o r s were t o be i n c l u d e d , n o t j u s t t h e c o a l t a r c o l o r s ; t h e S e c r e t a r y was t o d e t e r m i n e w h i c h c o l o r s were t o be c e r t i f i e d and w h i c h w o u l d b e exempted; p r o d u c e r s and c o n s u m e r s were t o p r o v i d e d a t a t o o b t a i n permanent l i s t i n g s ; and p r o v i s i o n a l l i s t i n g r e f e r r e d t o c o l o r s f o r w h i c h a d d i t i o n a l d a t a were n e c e s s a r y t o s e c u r e permanent l i s t i n g . Uses o f C o l o r s F o o d s . C o l o r s a r e added ( 1 ) t o f o o d s t h a t have no c o l o r o f t h e i r own ( b e v e r a g e s , g e l a t i n d e s s e r t , c a n d i e s , i c e c r e a m ) ; (2) where t h e n a t u r a l c o l o r h a s been l o s t i n p r o c e s s i n g o r s t o r a g e ; (3) where c o l o r o f t h e f o o d v a r i e s w i t h t h e s e a s o n o f the y e a r (geographic o r i g i n , f o r example d a i r y products, oranges); ( 4 ) t o make f o o d s r e c o g n i z a b l e and a t t r a c t i v e , e n h a n c i n g t h e i r a e s t h e t i c v a l u e . T h e meat i n s p e c t i o n stamp i s also colored. D r u g s . C o l o r s a r e added t o d r u g s f o r p u r p o s e s o f i d e n t i f i c a t i o n , s t a n d a r d i z i n g b a t c h e s , t o mask u n s a t i s f a c t o r y n a t u r a l c o l o r s , and f o r a p p e a l ( c o l o r l e s s p r o d u c t s a r e not a e s t h e t i c ) . Cosmetics. Cosmetics r e q u i r e the a d d i t i o n o f c o l o r s f o r e f f e c t i v e n e s s . C o l o r s may b e added t o e n h a n c e t h e a e s t h e t i c v a l u e , f o r example t o a f t e r s h a v e l o t i o n a n d shampoo, o r t o s e r v e a f u n c t i o n a l p u r p o s e , f o r example i n eye brow p e n c i l , n a i l p o l i s h ,

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

314

X E N O B I O T I C S IN F O O D S A N D

l i p s t i c k , e t c . T h e amounts u s e d i n c o s m e t i c s i s used i n f o o d s and d r u g s . Acceptable

i s greater

FEEDS

than

D a i l y Intake (API)

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

The amount o f t h e m a t e r i a l t h a t c a n be i n g e s t e d w i t h o u t u n r e a s o n a b l e r i s k o f a d v e r s e h e a l t h e f f e c t s may be c o n s i d e r e d an a c c e p t a b l e d a i l y i n t a k e . This r e f e r s p r i m a r i l y t o food c h e m i c a l s . T o a r r i v e a t an a c c e p t a b l e d a i l y i n t a k e , a p p r o p r i a t e t o x i c o l o g i c a l t e s t s a n d s a f e t y f a c t o r s a r e i n v o l v e d . ADIs h a v e been e s t a b l i s h e d b y t h e U.S. F o o d a n d Drug A d m i n i s t r a t i o n , t h e W o r l d H e a l t h O r g a n i z a t i o n , t h e J o i n t E x p e r t Committee o n F o o d A d d i t i v e s , and t h e E u r o p e a n E c o n o m i c Community. B a c k g r o u n d o f t h e C u r r e n t T e s t i n g Program The Food and Drug A d m i n i s t r a t i o n d e t e r m i n e d t h a t t h e p r o v i s i o n a l l i s t i n g o f c o l o r s was t o be e l i m i n a t e d . C o l o r s were t o be e i t h e r p e r m a n e n t l y l i s t e d o r t o b e p r o h i b i t e d f r o m u s e . A l s o , t h e r e was c o n c e r n a b o u t c o l o r s t h a t were p e r m a n e n t l y l i s t e d . The c o n c e r n was n o t b a s e d o n a d v e r s e h e a l t h e f f e c t s n o r on t h e g e n e r a t i o n o f a s i g n i f i c a n t amount o f t o x i c o l o g i c a l d a t a , but p r e s u m a b l y o n a t e r a t o l o g y s t u d y o f Aramanth (Red No. 2) t h a t a p p e a r e d i n R u s s i a n l i t e r a t u r e . The f i n d i n g s were n o t c o n f i r m e d when t h e s t u d y was r e d o n e b y t h e Food and Drug A d m i n i s t r a t i o n and by t h e C e r t i f i e d C o l o r s Manufacturers A s s o c i a t i o n . T h e r e was some c o n c e r n t h a t c o l o r s were n o t n e c e s s a r y s i n c e t h e y are non-nutrive. This neglects t h e aesthetic value o f foods. C o l o r s were a l s o r e - e v a l u a t e d , p r e s u m a b l y b e c a u s e o f t h e c y c l i c r e v i e w a n d r e - e v a l u a t i o n p r o g r a m a t FDA. T h e i n d u s t r y was r e q u e s t e d b y FDA t o r e - t e s t a l l FD a n d C and D and C c o l o r s . S p e c i f i c a l l y , t h e c o l o r m a n u f a c t u r e r s were r e q u e s t e d t o p r o v e s a f e t y . I f s a f e t y i s d e f i n e d as t h e absence o f t o x i c i t y , then i t can never be proved s i n c e one cannot prove a n e g a t i v e . I f s a f e t y i s d e f i n e d a s t h e v e r y l o w p r o b a b i l i t y t h a t an a d v e r s e e f f e c t w i l l o c c u r under c e r t a i n c o n d i t i o n s o f u s e , t h e n a p p r o p r i a t e s t u d i e s c a n b e d e s i g n e d and l e v e l s d e t e r m i n e d . H a r m l e s s n e s s must b e d e f i n e d under c e r t a i n c o n d i t i o n s o f u s e . I n o r d e r t o r e s p o n d t o FDA's r e q u e s t , l i f e - t i m e s t u d i e s were c o n d u c t e d i n t h e mouse a n d t h e r a t t o e s t a b l i s h s a f e t y ( r e a s o n a b l e c e r t a i n t y t h a t no harm w i l l o c c u r when t h e m a t e r i a l i s used under certain conditions). P r i o r t o i n i t i a t i n g these s t u d i e s , a thorough search o f the l i t e r a t u r e was c o n d u c t e d a n d t h e e x t e n t o f o r a l t o x i c i t y t e s t s was d e t e r m i n e d . I t was f o u n d t h a t t h e c o l o r s have a v e r y l o w o r d e r o f a c u t e o r a l t o x i c i t y . An e x p e r i m e n t a l d e s i g n was t h e n developed. P o t e n t i a l r e p r o d u c t i v e t o x i c i t i e s were e v a l u a t e d i n multigeneration r e p r o d u c t i v e and t e r a t o l o g i c a l s t u d i e s . No a d v e r s e e f f e c t s were r e p o r t e d a t any o f t h e l e v e l s e x a m i n e d .

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

20.

BORZELLECA ET

Experimental

AL.

Food,

Drug,

and Cosmetic

Colors

315

Design

The FD and C c o l o r s e v a l u a t e d a r e l i s t e d i n Table I. The c h e m i c a l s t r u c t u r e s , m o l e c u l a r w e i g h t s and c h e m i c a l names a p p e a r i n Table i i . The suppliers o f t h e colors a r e i d e n t i f i e d i n Table i n . O t h e r e x p e r i m e n t a l d e t a i l s a r e summarized i n Tables i v

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

through V I I .

The c h r o n i c t o x i c i t y / c a r c i n o g e n i c i t y s t u d i e s were d e s i g n e d as d e f i n i t i v e s t u d i e s t o a d d r e s s t h e i s s u e o f s a f e t y . T h e e x p e r i m e n t a l d e s i g n i n v o l v e d j_n u t e r o e x p o s u r e o f r a t s and t h e use o f w e a n l i n g m i c e . O n l y c e r t i f i e d b a t c h e s o f c o l o r f r o m t h e v a r i o u s s u p p l i e r s were u s e d . Two l a b o r a t o r i e s were s e l e c t e d f o l l o w i n g an e x t e n s i v e e v a l u a t i o n o f t h e f a c i l i t i e s a v a i l a b l e at that time. The c o l o r s were a n a l y z e d on a r e g u l a r b a s i s t o e v a l u a t e s t a b i l i t y , and m i c r o b i o l o g i c a l contamination. Feed analyses were c o n d u c t e d o n a w e e k l y b a s i s f o r t h e f i r s t 13 weeks o f t h e s t u d y , and t h e n a t m o n t h l y i n t e r v a l s t h e r e a f t e r b y t h e c o n t r a c t l a b o r a t o r y a n d b y i n d e p e n d e n t l a b o r a t o r i e s . Good l a b o r a t o r y p r a c t i c e s monitoring occurred a t l e a s t monthly. Results The r e s u l t s o f t h e s e s t u d i e s a r e summarized i n T a b l e s V I I I through XIII. These data f a i l e d t o i d e n t i f y any carcinogenic p o t e n t i a l o f t h e F o o d , Drug and C o s m e t i c c o l o r s . T h e r e were no c o n s i s t e n t , b i o l o g i c a l l y s i g n i f i c a n t compound-related e f f e c t s a t any l e v e l in e i t h e r species. Future

Studies

The g e n e t i c t o x i c o l o g i c a l a s p e c t s o f t h e c o l o r s a r e b e i n g evaluated. The data generated t o date f a i l e d t o demonstrate g e n o t o x i c i t y o f t h e s i x F D and C c o l o r s e v a l u a t e d . Comparative b i o t r a n s f o r m a t i o n and k i n e t i c s t u d i e s a r e e s s e n t i a l and t h e s e are i n p r o g r e s s . Special studies are being considered i n c l u d i n g i n t e r a c t i o n s , s e n s i t i z a t i o n o r a l l e r g i e s , and a s s e s s m e n t o f t h e v a l u e o f c o l o r i n human n u t r i t i o n . Summary and

Conclusions

The F o o d , Drug a n d C o s m e t i c c o l o r s h a v e been e x t e n s i v e l y e v a l u a t e d ( f e w f o o d c h e m i c a l s have been s o e x t e n s i v e l y s t u d i e d ) . The F o o d , Drug and C o s m e t i c c o l o r s d o n o t p o s e a t h r e a t t o human health a t l e v e l s c u r r e n t l y i n use o r a t l e v e l s greater than t h o s e c u r r e n t l y u s e d . T h e r e i s no b i o l o g i c a l e v i d e n c e i n a n i m a l s o r human t h a t t h e F o o d , Drug and C o s m e t i c c o l o r s a r e u n s a f e o r h a z a r d o u s t o human h e a l t h .

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

FD and C B l u e No. 1 FC and C G r e e n No. 3 FD and C B l u e No. 2 FD and C Y e l l o w No. 6 FD and C Y e l l o w No. 5 FD and C Red No. 3

T r i phenylmethane:

Indigoid:

Monoazo:

Pyrazolone:

Xanthene:

Chemical C l a s s

(Erythrosine) (Tetraiodo Fluorescein)

(Tartrazine)

(Sunset Yellow FCF)

(Indigotine)

1907

1916

1929

1907

1929 1927

Year approved by FDA/USDA ( B r i l l i a n t Blue FCF) ( F a s t Green FCF)

Chronic Toxicity Studies 1977-1981

FD AND C COLORS

Table I

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

20.

BORZELLECA E T AL.

Table

II.

Food,

and Cosmetic

x

Empirical

FD&C Red Red No. No. 40 FD&C 40 ( A l l u r a Red AC) FD&C Red No. : 3 (Erythrosine)

H

N

Formula

C

18 14°8 2 2

C

20 6 4

H

I

N a

S

N a

2

2°5

FD&C Y e l l o w No. 5

n

Q

Weights

M o l e c u l a r Weijght

496.40

9 1 2

C,,H N.Na 0 S 16 9 4 3 9 2

\

317

879.87

VeWs frr,

Colors

Çhem i ç a^l _S t^uc^jur e s . Name sj,. _ a n d __Mo 1 e çu l a r o f t h e FD&C C o l o r s E v a l u a t e d

Color

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

Drug,

Q

o

·

1 0

534.37

(Tartrazme) FD&C YYeellllooww No. 6 (Sunset Y e l l o w FCF) FD&C B l u e No. No 2 (Indigotine) FD&C G re ee en n Ν FD&C Gr No. 3 ( F a s t Green FCF)

C

16 10 2

H

C

16 8 2

C

37 34 2

H

H

N

N

N

N a

N a

S

2°7 2

S

2°8 2

N a

452.37

466.36

S

2°10 3

Continued

808.86

on n e x t

page

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

318

X E N O B I O T I C S IN F O O D S A N D

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

Table

II.

Chemical

S t r u c t u r e s ,

Color

Dye

FD&C Red No. 40 ( A l l u r a Red AC)

Monoazo

FD&C

Xanthene

Red

No.

3

Names,

Type

and

Molecular

Weights

Structure

(Erythrosine)

FD&C

Yellow

No.

5

Pyrazolone

6

Monoazo

(Tartrazine)

FD&C

Yellow

(Sunset

FD&C

No.

Yellow

Blue

FCF)

2

No.

Indigoid

(Indigotine) H

FD&C (Fast

Green Green

No.

3

FEEDS

0

Triphenylmethane

FCF)

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

20.

of

BORZELLECA ETAL.

Drug,

t h e FD&C C o l o r s E v a l u a t e d —

Chemical

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

Food,

and Cosmetic

Colors

Continued

CFR

Name

Reference

Disodium s a l t of 6-hydroxy-5[(2-methoxy-5-methyl-4-sulfophenyl)azo]-2-napththalenesulfonic acid

21 CFR

74.340

Monohydrate of 9-(0-carboxyphenyl)-6-hydroxy-2,4,5,7-tetraiodo3H-xanthen-3-one, d i s o d i u m o r d i p o t a s s i u m s a l t , w i t h s i m i l a r amounts o f l o w e r iodinated fluoresceins

21 CFR

74.303

5-0xo-l-(p-sulfophenyl)-4-[(p-sulfophenyl)azo]-2-pyrazoline-3-carboxy1ic acid, trisodium salt

21 CFR

74.705

Disodium s a l t of 1-p-sulfophenylazo-2-naphthol-6-sulfonic acid

21 CFR

82.706

P r i n c i p a l l y the disodium s a l t , o f 5,5'-disulfo-3,3'-dioxo- Δ ' b i i n d o l i n e w i t h s m a l l e r amounts o f the i s o m e r i c disodium^sg].t o f 5,7 disulfo-3,3'-dioxo-Δ ' -biindoline

21 CFR

74.1102

4-[(4-Εthy1-p-sulfobenzylamino)phenyl]-(4-hydroxy-2-sulfoniumphenyl)methylene^-[l-(N-ethyl-N-p-sulfobenzyl)-A ' -cyclohexadienimine]

21 CFR

82.203

f

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

X E N O B I O T I C S IN F O O D S A N D

FEEDS

Table III FD AND C COLORS

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

Chronic T o x i c i t y Studies 1977-1981

SUPPLIERS OF COLORS Color

Manufacturer

FD and C B l u e No. 1

H i l t o n - D a v i s Chemical Co.

FD and C G r e e n No. 3

Warner-Jenkinson Co.

FD and C B l u e No. 2

H i l t o n - D a v i s Chemical Co.

FD and C Y e l l o w No. 6

Stange Co. H i l t o n - D a v i s Chemical Co.

FD and C Y e l l o w No. 5 Warner-Jenkinson Co. FD and C Red No. 3 H. Kohnstamm

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

Rat Mouse

International Research and Development C o r p .

P u r i n a Rodent L a b o r a t o r y Chow P u r i n a Rodent L a b o r a t o r y Chow A f t e r 8/79: Purina Certified L a b o r a t o r y Chow

R a t and Mouse R a t and Mouse

International Research and Development C o r p .

Feed

P o r t a g e , MI

C h a r l e s R i v e r CD R a t s C h a r l e s R i v e r CD-I M i c e

Species

W i l m i n g t o n , MA

Colony

C h a r l e s R i v e r CD R a t s C h a r l e s R i v e r CD-I M i c e

Strain

Biodynamics

Laboratory

ANIMAL FEED

Rat Mouse

Biodynamics

MATERIALS AND METHODS:

Species

ANIMALS

Laboratory

MATERIALS AND METHODS:

Chronic Toxicity Studies 1977-1981

FD AND C COLORS

T a b l e IV

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

X E N O B I O T I C S IN F O O D S A N D

322

FEEDS

Table V FD AND C COLORS Chronic T o x i c i t y Studies 1977-1981 MATERIALS AND METHODS:

MICE

( C h a r l e s R i v e r , CD-I)

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

Observation General changes, moribundity, m o r t a l i t y (3 χ d a i l y ) Body W e i g h t / F o o d C o n s u m p t i o n ( w e e k l y : weeks 1-14; b i - w e e k l y : weeks 16-26 e v e r y 4 weeks t h e r e a f t e r ) Detailed Physical Examination ( w e e k l y : weeks 1-14; b i - w e e k l y : weeks 16-16; e v e r y 4 weeks t h e r e a f t e r )

Pathology Gross pathology on a l l animals DOS a n i m a l s Terminal

Sacrifice

Statistical Analysis Appropriate tests

Test Diet Analysis Independent a n a l y s i s by c o n t r a c t l a b and CCMA member company l a l

C l i n i c a l Laboratory Tests H e m a t o l o g y ( 3 , 6, 12, 18 months; terminal) Hemoglobin Hematocrit Total erythrocyte E r y t h r o c y t e morphology T o t a l and d i f f e r e n t i a l l e u c o c y t e (10 Μ , 10 F f r o m each g r o u p )

Histopathology Adrenal (2) A o r t a (abdominal) Bone and bone marrow ( f e m u r ) B l o o d smear B r a i n (3 s e c t i o n s , i n c l u d i n g f r o n t a l c o r t e x and b a s a l g a n g l i a , p a r i e t a l c o r t e x and t h a l a m u s ; c e r e b e l l u m and p o n s ) Esophagus Eye ( 2 - w i t h o p t i c n e r v e ) Gall bladder Heart (with coronary v e s s e l s ) Intestine cecum colon duodenum ileum Kidneys (2) Liver (2) Lung and m a i n s t e m b r o n c h i Lymph nodes (mesenteric, mediastinal)

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

BORZELLECA ET AL.

Food,

Table V

Drug,

and Cosmetic

Colors

(Continued)

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

Histopathology Mammary g l a n d ( i n g u i n a l ) Nerve ( s c i a t i c ) Ovaries Pancreas Pituitary Prostate S a l i v a r y gland (mandibular) S e m i n a l v e s i c l e s (2) S k e l e t a l muscle (biceps femoris) Skin Spinal cord ( c e r v i c a l ) Spleen Stomach Testes with epididymides Thymus Thyroid/parathyroid Trachea Urinary bladder Uterus Gross changes o r u n c e r t a i n nature (including a s e c t i o n o f normala p p e a r i n g p o r t i o n o f same tissue) T i s s u e masses o r s u s p e c t tumors w i t h r e g i o n a l lymph nodes

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

X E N O B I O T I C S IN F O O D S A N D

324

FEEDS

T a b l e VI FD AND C COLORS Chronic T o x i c i t y Studies 1977-1981 MATERIALS AND METHODS:

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

In U t e r o

RATS

Segment

Group

Male

Female

M i n . No. L i t t e r s

Dosage L e v e l s

1-A

60

60

70

Control

1-B

60

60

70

Control

2

60

60

35

Low

3

60

60

35

Mid

4

60

60

35

High

RANDOM SELECTION

Chronic Feeding

Segment

Group

Male

Female

Dosage L e v e l s

1-A

70

70

Control

1-B

70

70

Control

2

70

70

Low

3

70

70

Mid

4

70

70

High

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

20.

BORZELLECA ET AL.

Food,

Drug,

and Cosmetic

Colors

325

Table VII FD AND C COLORS Chronic T o x i c i t y Studies 1977-1981 MATERIALS AND METHODS:

RATS ( C h a r l e s R i v e r , CD-I)

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

Observation General changes, moribundity,) m o r t a l i t y (3 χ d a i l y ) Body W e i g h t / F o o d C o n s u m p t i o n ( w e e k l y : weeks 1-14; b i - w e e k l y : weeks 16-26 e v e r y 4 weeks t h e r e a f t e r ) Detailed Physical Examination ( w e e k l y : weeks 1-14; b i - w e e k l y : weeks 16-16; e v e r y 4 weeks t h e r e a f t e r ) Pathology Gross pathology on a l l animals DOS a n i m a l s Interim S a c r i f i c e Terminal S a c r i f i c e

C l i n i c a l Laboratory

Tests

H e m a t o l o g y ( 3 , 6, 12, 1 8 , 24 months; t e r m i n a l ) Hemoglobin Hematocrit Total erythrocyte E r y t h r o c y t e morphology T o t a l and d i f f e r e n t i a l l e u c o c y t e (10 M, 10 F f r o m e a c h g r o u p ) B l o o d C h e m i s t r y ( 3 , 6, 1 2 , 18, 24 months; t e r m i n a l ) Serum g l u t a m i c o x a l o a c e t i c transaminase Serum g l u t a m i c p y r u v i c transaminase A l k a l i n e phosphatase Blood urea nitrogen Fasting glucose Total protein Creatinine

U r i n a l y s i s ( 3 , 6, 1 2 , 18 24 months; t e r m i n a l ) Gross appearance Appropriate tests Specific gravity pH Protein Test Diet Analysis Glucose Ketones Independent a n a l y s i s by c o n t r a c t Bilirubin l a b and CCMA member company l a i O c c u l t b l o o d Microscopic analysis Statistical Analysis

(Continued)

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

326

X E N O B I O T I C S IN F O O D S A N D

T a b l e VII

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

Histopathology Adrenal (2) Aorta (abdominal) B l o o d smear Bone and bone marrow ( f e m u r ) B r a i n (3 s e c t i o n s , i n c l u d i n g f r o n t a l c o r t e x and b a s a l g a n g l i a , p a r i e t a l c o r t e x and t h a l a m u s ; c e r e b e l l u m and pons) Esophagus E y e (2 - w i t h o p t i c n e r v e ) Heart (with coronary v e s s e l s Intestine cecum colon duodenum ileum Kidneys (2) Liver (2) Lung and m a i n s t e m b r o n c h i Lymph nodes (mesenteric, mediastinal) Mammary g l a n d ( i n g u i n a l ) Nerve ( s c i a t i c ) Ovaries Pancreas Pituitary Prostate S a l i v a r y gland (mandibular) Seminal v e s i c l e s ( 2 ) S k e l e t a l muscle (biceps femoris) Skin Spinal cord ( c e r v i c a l ) Spleen Stomach Testes with epididymides Thymus Thyro i d/parathyro i d Trachea Urinary bladder Uterus Gross changes o f u n c e r t a i n nature (including a s e c t i o n o f normala p p e a r i n g p o r t i o n o f same t i s s u e ) T i s s u e masses o r s u s p e c t tumors w i t h r e g i o n a l lymph nodes

FEEDS

(Continued) Ophthalmoscopic

Examination

3, 6, 12, 18, 24 months

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

Controls

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

2 Concurrent Controls

5.0% (7500 mg/kg/day)

1.5% (2250 mg/kg/day)

0 . 5 % (750 mg/kg/day)

60/Sex/Group

2 Concurrent

2.0% (1000 mg/kg/day)

1.0% (500 mg/kg/day)

0 . 1 % (50 mg/kg/day)

70/Sex/Group

Number/Group Dose L e v e l s

F e m a l e s - 2 8 — 3 0 A p r i l 1980

M a l e s - 28-30 A p r i l 1978

Termination:

26 A p r i l 1978

Initiation:

F e m a l e s - 15 November 1979

M a l e s - 28 December 1979

Termination:

11 O c t o b e r 1977

Initiation:

Initiation Termination

No c o n s i s t e n t biologically significant compound r e l a t e d adverse e f f e c t s

No c o n s i s t e n t biologically significant compound r e l a t e d adverse e f f e c t s

Effects

9

ρ

to

a.

is

fx to S

ο

?

>

^

Co

S"

Cosm etic d

Mouse

Rat

Species

FD AND C BLUE NO. 1

I n t e r n a t i o n a l R e s e a r c h and D e v e l o p m e n t C o r p o r a t i o n

Table VIII

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

ELLECA ET

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

Mouse

Rat

Species

2 Concurrent Controls

5.σ/ο (7500 mg/kg/day)

16 May 1980

Termination:

11 May 1978

0.5% (750 mg/kg/day)

1.5% (2250 mg/kg/day)

Initiation:

F e m a l e s - 18 A p r i l 1980

M a l e s - 4 March 1980

Termination:

60/Sex/Group

2 Concurrent Controls

5.0% (2500 mg/kg/day)

2.5% (1250 mg/kg/day)

12 O c t o b e r 1977

Initiation:

Initiation Termination Effects

No c o n s i s t e n t biologically significant compound r e l a t e d adverse e f f e c t s

Statistically significant increase i n hyperplasia and t u m o r s i n u r i n a r y b l a d d e r s o f high-dose male rats.

FD AND C GREEN NO. 3 B i o / D y n a m i c s , I n c .

1.25% (625 mg/kg/day)

70/Sex/Group

Number/Group Dose L e v e l s

T a b l e IX

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

2 Concurrent C o n t r o l s

5.054 (7500 mg/kg/day)

1.554 (2250 mg/kg/day)

Males - 21-22 February 1980

Termination:

No c o n s i s t e n t biologically significant compound r e l a t e d adverse e f f e c t s

*Not b i o l o g i c a l l y significant

Females - 3-4 A p r i l 1980

l b May 1978

Mammary Tumors (Males)*

Males - 18-19 February 1980

0.554 (750 mg/kg/day)

Bladder Tumors (Males)*

Termination:

Initiation:

B r a i n Gliomas and Granular C e l l Tumors (Males)*

Effects

18 October 1977

Initiation:

60/Sex/Group

2 Concurrent C o n t r o l s

2.σ/ο (1000 mg/kg/day)

1.0% (500 mg/kg/day)

0.5% (250 mg/kg/day)

70/Sex/Group

Initiation Termination

Females - 14-15 A p r i l 1980 * S t a t i s t i c a l l y s i g n i f i c a n t with high dose males only

Mouse

Rat

Species

Number/Group Dose L e v e l s

Bio/Dynamics, Inc.

FD AND C BLUE NO. 2

Table Χ

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

Κ)

s

o

o

> r

H

r r m n >

Ν M

*>

Ο

Ο

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

Mouse

Rat

Species

2 Concurrent Controls

5.σ/ο (7500 mg/kg/day)

Females - 30 March 1980

Males - 29 December 1979

Termination:

16 May 1978

0.5% (750 mg/kg/day)

1.5/o (2250 mg/kg/day)

Initiation:

60/Sex/Group

5.σ/ο - March 1981

Females - 7 March 1980

Males - 22 A p r i l 1980

5.σ/ο (2500 mg/kg/day) Controls

Termination:

3.σ/ο (1500 mg/kg/day)

2 Concurrent

5.σ/ο - 26 February 1979

3 November 1977

Initiation:

Initiation Termination

1.5/o (750 mg/kg/day)

0.75/o (375 mg/kg/day)

70/Sex/Group

Number/Group Dose Levels

Bio/Dynamics, Inc.

FD AND C YELLOW NO. 6

Table XI

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

No c o n s i s t e n t biologically significant compound r e l a t e d adverse e f f e c t s

No c o n s i s t e n t biologically significant compound r e l a t e d adverse e f f e c t s

Effects



Ό

m m

τ]

> Ζ σ

Ό

τι Ο Ο

η

Η

X m ζ ο 2 δ

°

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

Mouse

Rat

Species

Termination:

2.0% (1000 mg/kg/day)

2 Concurrent Controls

5.0% (7500 mg/kg/day)

2 May 1980

Termination:

3 May 1978

0.5% (750 mg/kg/day)

1.5% (2250 mg/kg/day)

Initiation:

5.0» - 24 F e b r u a r y 1981

60/Sex/Group

2 Concurrent Controls

5.0% - 9 O c t o b e r 1978

1.0% (500 mg/kg/day)

31 December 1980

25 O c t o b e r 1977

Initiation:

Initiation Termination

0 . 1 % (50 mg/kg/day)

70/Sex/Group

Number/Group Dose L e v e l s

Table XII FD AND C YELLOW NO. 5 I n t e r n a t i o n a l R e s e a r c h and D e v e l o p m e n t C o r p o r a t i o n

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

No c o n s i s t e n t biologically significant compound r e l a t e d adverse e f f e c t s

No c o n s i s t e n t biologically significant compound r e l a t e d adverse e f f e c t s

Effects

Finley and Schwass; Xenobiotics in Foods and Feeds ACS Symposium Series; American Chemical Society: Washington, DC, 1983.

Mouse

Rat

Species

2 Concurrent

Controls

3.054 (4500 mg/kg/day)

1.054 (1500 mg/kg/day)

0.3% (500 mg/kg/day)

60/Sex/Group

Controls

(50 mg/kg/day) (250 mg/kg/day) (500 mg/kg/day) (2000 mg/kg/day)

2 Concurrent

0.1% 0.5% 1.054 4.054

70/Sex/Group

Number/Group Dose L e v e l s

I n t e r n a t i o n a l Research

Table XIII

23 A p r i l 1980

Termination:

25 A p r i l 1978

Initiation:

27 March 1980 4% - 24 F e b r u a r y 1981

Termination:

18 O c t o b e r 1977 4% - 4 O c t o b e r 1978

Initiation:

Initiation Termination

and D e v e l o p m e n t C o r p o r a t i o n

FD AND C RED NO. 3

Downloaded by UNIV OF ARIZONA on April 25, 2017 | http://pubs.acs.org Publication Date: October 25, 1983 | doi: 10.1021/bk-1983-0234.ch020

No c o n s i s t e n t biologically significant compound r e l a t e d adverse e f f e c t s

No c o n s i s t e n t biologically significant compound r e l a t e d adverse e f f e c t s

Effects